Nano-X Imaging (NNOX) Cash from Financing Activities (2021 - 2025)
Nano-X Imaging's (NNOX) quarterly Cash from Financing Activities came in at $15.5 million in Q4 2025, down 59.01% YoY from $37.8 million in Q4 2024, and up 170.35% on a QoQ basis from $5.7 million in Q3 2025.
Nano-X Imaging (NNOX) Cash from Financing Activities (2021 - 2025) Analysis & Trends
Nano-X Imaging (NNOX) has 5 years of Cash from Financing Activities data on file, last reported at $15.5 million in Q4 2025.
- Quarterly Cash from Financing Activities fell 59.01% year-over-year to $15.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.4 million (down 45.91% YoY) and the FY2025 annual result came in at $21.4 million, down 45.91% from the prior year.
- Cash from Financing Activities grew to $15.5 million in Q4 2025, from $5.7 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $37.8 million in Q4 2024 to a low of -$12.0 million in Q2 2021.
- A 5-year average of $5.1 million and a median of $176000.0 in 2023 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities slumped 368.84% — and 2024, when it jumped 114560.61%.
- Tracing NNOX's Cash from Financing Activities over 5 years: stood at $1.0 million in 2021, then plunged by 83.33% to $174000.0 in 2022, then sank by 81.03% to $33000.0 in 2023, then jumped by 114560.61% to $37.8 million in 2024, then slumped by 59.01% to $15.5 million in 2025.
- The last three Cash from Financing Activities figures came in at $15.5 million (Q4 2025), $5.7 million (Q3 2025), and $121000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Nano-X Imaging | 61,578.01 | -44.16 Mn | -2.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.51 Mn |
| Dec 31, 2025 | 15.51 Mn |
| Sep 30, 2025 | 5.74 Mn |
| Sep 30, 2025 | 5.74 Mn |
| Mar 31, 2025 | 121,000.00 |
| Mar 31, 2025 | 121,000.00 |
| Dec 31, 2024 | 37.84 Mn |
| Dec 31, 2024 | 37.84 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 21,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Sep 30, 2023 | 27.41 Mn |
| Sep 30, 2023 | 27.41 Mn |
| Jun 30, 2023 | -371,000.00 |
| Jun 30, 2023 | -371,000.00 |